# Contact Us

**Boehringer Ingelheim Limited and Boehringer Ingelheim Animal Health UK Limited**  
Ellesfield Avenue  
Bracknell  
Berkshire  
RG12 8YS  
United Kingdom  
Tel: +44 (0) 1344 424600  
Fax: +44 (0) 1344 741444

If you think you or a patient is experiencing a side effect from a medicinal product, or if a medicine or medical device is giving any other cause for concern, this may be an “adverse event”. Adverse events should always be reported.

To report an event following exposure to a Boehringer Ingelheim **Human Health** Product, [click here](/content/uk/about-us/adverse-events/index.html)  
To report a potential side effect or adverse event after exposure to a Boehringer Ingelheim **Animal Health** product, [click here](/content/uk/contact-us/veterinary-product-adverse-events/index.html).

For UK and Ireland Medical information enquiries (human medicines):  
Tel: 44 (0) 1344 742579  
[medinfo.bra@boehringer-ingelheim.com](mailto:medinfo.bra@boehringer-ingelheim.com)

For Ireland Veterinary enquiries:  
Tel: 01 291 3985 (all queries)  
[vetenquiries@boehringer-ingelheim.com](mailto:vetenquiries@boehringer-ingelheim.com)

For UK Veterinary enquiries:  
Tel: 44 (0) 1344 746959 (sales)  
Tel: 44 (0) 1344 746957 (technical)  
[vetenquiries@boehringer-ingelheim.com](mailto:vetenquiries@boehringer-ingelheim.com)

For Pet Owner enquiries:  
[petsuk@boehringer-ingelheim.com](mailto:petsuk@boehringer-ingelheim.com)

For Media enquiries:  
Please call (0) 1344 741155 or contact us via the form below.

For any other UK and Ireland enquiries:  
Please contact us via the form below.

If you are not already supplying goods or services to Boehringer Ingelheim in the UK and/or Ireland and wish to be considered as a new supplier please complete the attached form via this link. [New Supplier Form](/content/uk/about-us/purchasing/supplier-contact-form/index.html).

For directions to our head office in Berkshire, please download our [location map](/content/uk/pdf/bracknell-office-directions/index.html).

Thank you for your interest in Boehringer Ingelheim. We welcome your queries and feedback.